Cogprints

Devices for Prevention of Atrial Tachyarrhythmias

Fernández Lozano, Ignacio and Toquero, Jorge and Fernández Díaz, José Antonio and Ionescu, Bogdan and Moñivas, Vanesa and Ortiz, Pilar and Fuertes, Beatriz (2004) Devices for Prevention of Atrial Tachyarrhythmias. [Journal (Paginated)]

Full text available as:

[img] HTML
93Kb
[img]
Preview
 PDF
262Kb

Abstract

Atrial fibrillation (AF) is the most frequent sustained cardiac arrhythmia in clinical practice and, although its importance has been underestimated even in recent years, we are now becoming aware of its clinical transcendence1,2,3. The classical treatment is pharmacological, but its efficacy is limited and it does have side effects4,5. Therefore, in recent years, there has been an increasing interest in other types of non-pharmacological treatments6,7. Physiologic cardiac pacing has proven to be more effective than VVI mode pacing to prevent the occurrence of AF during the follow-up of patients who have had a permanent pacemaker implanted 8,9,10. There are currently different lines of research that use different atrial pacing techniques to prevent and treat episodes of paroxysmal atrial fibrillation11,12. Techniques of multi-site pacing in the right atrium or both atria, new atrial pacing sites, prevention algorithms for paroxysmal atrial fibrillation episodes, and even high-frequency atrial tachyarrhythmia termination algorithms have all been proposed. In this article, we will try to synthesize the grounds for and findings of the different lines of research currently being developed.

Item Type:Journal (Paginated)
Keywords:atrial fibrillation; atrial fultter; pacing; multisite
Subjects:JOURNALS > Indian Pacing and Electrophysiology Journal
ID Code:4228
Deposited By: Indian Pacing and Electrophysiology, Journal
Deposited On:17 Apr 2005
Last Modified:11 Mar 2011 08:55

References in Article

Select the SEEK icon to attempt to find the referenced article. If it does not appear to be in cogprints you will be forwarded to the paracite service. Poorly formated references will probably not work.

1. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham Study. N Engl J Med 1982;306:1018-22.

2. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med 1995;155:469-73.

3. Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98:946-52.

4. Coplen SE, Antman EM, Berlin JA, Hewitt P, and Chalmers TC. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: a metaanalysis of randomized controlled trials Circulation 1990, 82:1106–1116.

5. Falk RH. Proarrhythmia in patients treated for atrial fibrillation or flutter. Ann Intern Med 1992;117:141-50.

6. Cox JL, Schuessler RB, D’Agostino HJ, Stone CM, Byung-Chul CH, Cain ME et al. The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg 1991;101:569-83.

7. Jais P, Haissaguerre M, Shah DC, Chouairi S, Gencel L, Hocini M, and Clementy J. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 1997; 95: 572-6.

8. Andersen HR, Nielsen JC, Thomsen PEB, Thuesen L, Mortensen PT, Vesterlund T et al. Long-term follow-up of patients from a randomized trial of atrial versus ventricular pacing for sick sinus syndrome. Lancet 1997, 350:1210–1216.

9. Skanes AC, Krahn A, Yee R, Klein GJ, Connolly SJ, Kerr CR et al. Progression to chronic atrial fibrillation after pacing: the Canadian trial of physiologic pacing. CTOPP investigators. J Am Coll Cardiol 2001 Jul, 38:167–172.

10. Lamas GA, Lee K, Sweeney M, Leon A, Yee R, Ellenbogen K, et al. for the MOST Investigators. The mode selection trial (MOST) in sinus node dysfunction: Design, rationale, and baseline characteristics of the first 1000 patients. Am Heart J 2000, 140:541– 551.

11. Daubert C, Mabo P, Berder V. Atrial tachyarrhythmias associated with high degree interatrial conduction block: Prevention by permanent atrial resynchronization. Eur JCPE 1994, 4:35–44.

12. Saksena S, Prakash A, Hill M, Krol RB, Munsif AN, Mathew PP, Mehra R. Prevention of recurrent atrial fibrillation with chronic dual site right atrial pacing. J Am Coll Cardiol 1996, 28:687–694.

13. Wijfells MC, Kirchhof CJ, Dorland RD, et al.: Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995, 92:1954–1968.

14. Saksena S, Prakash A, Krol RB, et al.: Organized and reproducible atrial activation is present globally and regionally during phases of human atrial fibrillation [abstract]. J Am Coll Cardiol 2000, 35:139.

15. Coumel P, Friocourt P, Mugica J, et al.: Long-term prevention of vagal atrial arrhythmias by atrial pacing at 90/minute: experience with 6 cases. PACE 1983, 6:552–560.

16. Attuel P, Pellerin D, Mugica J, et al.: DDD pacing: an effective treatment modality for recurrent atrial arrhythmias. PACE 1988, 11:1647–1654.

17. Fitts SM, Hill MR, Mehra R, et al.: Design and implementation of the dual site atrial pacing to prevent atrial fibrillation (DAPPAF) clinical trial. DAPPAF Phase 1 Investigators. J Intervent Card Electrophysiol 1998, 2:139–144.

18. Bailin SJ, Giudici MC, Solinger B, et al.: Pacing from Bachmann’s bundle prevents chronic atrial fibrillation: Final results from a prospective randomized trial [abstract]. PACE 2001, 24:227.

19. Prakash A, Saksena S, Hill M, et al.: Acute effects of dual-site right atrial pacing in patients with spontaneous and inducible atrial flutter and fibrillation. J Am Coll Cardiol 1997, 29:1007–1014.

20. Murgatroyd FD, Nitzsche R, Slade AKB, et al.: A new pacing algorithm for overdrive suppression of atrial fibrillation. PACE 1994, 17:1966–1973.

21. Prakash A, Saksena S, Ziegler P, et al. for the DAPPAF Investigators: Dual Site Atrial Pacing for Prevention of Atrial Fibrillation [DAPPAF] trial: echocardiographic evaluation of atrial and ventricular function during a randomized trial of support, high right atrial and dual site right atrial pacing [abstract]. PACE 2001, 24:57.

22. Israel CW, Huegl B, Unterberg-Buchwald et al.: Performance of a new implantable DDRP device incorporating preventive and antitachycardia pacing modalities: Results of the international prospective AT500 verification study. PACE 2001, 24:62.

23. Andersen HR, Thuesen L, Bagger JP, Vesterlund T, Thomsen PE: Prospective randomized trial of atrial versus ventricular pacing in sick sinus syndrome. Lancet 1994;344:1523-1528.

24. Nielsen JC, Andersen HR, Thomsen PE, Thuesen L, Mortensen PT, Vesterlund T, Pedersen AK: Heart failure and echocardiographic changes during long-term follow-up of patients with sick sinus syndrome randomized to single-chamber atrial or ventricular pacing. Circulation1998;97:987-995.

25. Andersen HR, Nielsen JC, Thomsen PE, Thuesen L, Pedersen AK, Mortensen PT, Vesterlund T: Arterial thromboembolism in patients with sick sinus syndrome: Prediction from pacing mode, atrial fibrillation, and echocardiographic findings. Heart 1999;81:412-418.

26. Lamas GA, Orav EJ, Stambler BS, Ellenbogen KA, Sgarbossa EB, Huang SK, Marinchak RA, Estes NA III, Mitchell GF, Lieberman EH, Mangione CM, Goldman L: Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared to with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators. N Engl J Med 1998;338:1097-1104.

27. Mattioli AV, Vivoli D, Mattioli G: Influence of pacing modalities on the incidence of atrial fibrillation in patients without prior atrial fibrillation. A prospective study. Eur Heart J 1998;19:282-286.

28. Connolly SJ, Kerr CR, Gent M, Roberts RS, Yusuf S, Gillis AM, Sami MH, Talajic M, Tang AS, Klein GJ, Lau C, Newman DM: Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med 2000;342:1385-1391.

29. Tang AS, Roberts RS, Kerr C, Gillis AM, Green MS, Talajic M, Yusuf S, Abdollah H, Gent M, Connolly SJ: Relationship Between Pacemaker Dependency and the Effect of Pacing Mode on Cardiovascular Outcomes. Circulation. 2001;103:3081-3085.

30. Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Yee R, Marinchak RA, Flaker G, Schron E, Orav EJ, Hellkamp AS, Greer S, McAnulty J, Ellenbogen K, Ehlert F, Freedman RA, Estes NA III, Greenspon A, Goldman L, for Mode Selection Trial in Sinus-Node Function: Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 2002;346:1854-1862.

31. Toff W, Skehan D: Late Breaking Clinical Trials oral presentation at the American College of Cardiology, March 2003.

32. Gillis AM, Wyse DG, Connolly SJ, Dubuc M, Philippon F, Yee R, Lacombe P, Rose MS, Kerr CD: Atrial pacing periablation for prevention of paroxysmal atrial fibrillation. Circulation 1999;99:2553-2558.

33. Gillis AM, Connolly SJ, Lacombe P, Philippon F, Dubuc M, Kerr CD, Yee R, Rose MS, Newman D, Kavanagh KM, Gardner MJ, Kus T, Wyse DG: Randomized crossover comparison of DDDR versus VDD pacing after atrioventricular junction ablation for prevention of atrial fibrillation. Circulation 2000;102:736-741.

34. Bayes de Luna A, Cladellas M, Oter R, Torner P, Guindo J, Marti V, Rivera I, Iturralde P: Interatrial conduction block and retrograde activation of the left atrium in paroxysmal supraventricular tachyarrhythmia. Eur Heart J 1988;9:1112-1118.

35. Daubert JC, Leclercq C, Pavin D, Mabo P: Biatrial synchronous pacing: A new approach to prevent arrhythmias in patients with atrial conduction block. In Daubert JC, Prystowsky EN, Ripart A, eds: Prevention of Tachyarrhythmias with Cardiac Pacing. Armonk, NY: Futura Publishing Co., 1997, pp. 99-119.

36. Pavin D, Revault D’Allonnes G, Mabo P, Daubert JC: Left atrial and biatrial pacing. In Israel CW, Barold SS, eds: Advances in the Treatment of Atrial Tachyarrhythmias: Pacing, Cardioversion and Defibrillation. Armonk, NY: Futura Publishing Co., 2002, pp. 79-98.

37. Revault d’Allonnes G, Pavin D, Leclercq C, Ecke JE, Jauvert G, Mabo P, Daubert JC: Long-term effects of biatrial synchronous pacing to prevent drug-refractory atrial tachyarrhythmia: A nine-year experience. J Cardiovasc Electrophysiol 2000;11:1081-1091.

38. Levy T, Fotopoulos G,Walker S, Rex S, Octave M, Paul V, Amrani M: Randomized controlled study investigating the effect of biatrial pacing in prevention of atrial fibrillation after coronary artery bypass grafting. Circulation 2000;102:1382-1387.

39. Daoud EG, Dabir R, Archambeau M, Morady F, Strickberger SA: Randomized, double-blind trial of simultaneous right and left atrial epicardial pacing for prevention of post-open heart surgery atrial fibrillation. Circulation 2000;102:761-765.

40. Fan K, Lee KL, Chiu CSW, Lee JWT, He GW, Cheung D, Sun MP, Lau CP: Effects of biatrial pacing in prevention of postoperative atrial fibrillation after coronary artery bypass surgery. Circulation 2000;102:755-760.

41. Saksena S, Prakash A, Ziegler P, Hummel JD, Friedman P, Plumb VJ, Wyse DG, Johnson E, Fitts S, Mehra R: Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy. J Am Coll Cardiol 2002;40:1140-1150.

42. Padeletti L, Porciani MC, Michelucci A, Colella A, Ticci P, Vena S, Costoli A, Ciapetti C, Pieragnoli P, Gensini GF: Interatrial septum pacing: A new approach to prevent recurrent atrial fibrillation. J Interv Card Electrophysiol 1999;3:35-43.

43. Padeletti L, Pieragnoli P, Ciapetti C, Colella A, Musilli N, Porcani MC, Ricci R, Pignalberi C, Santini M, Puglisi A, Azzolini P, Spampinato A, Martelli M, Cappucci A, Boriani G, Botto GL, Proclemer A: Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia. Am Heart J 2001;142:1047-1055.

44. Kale M, Bennett DH: Atrial septal pacing in the prevention of paroxysmal atrial fibrillation refractory to antiarrhythmic drugs. Int J Cardiol 2002;82:167-175.

45. Bailin SJ, Adler S, Giudici M: Prevention of chronic atrial fibrillation by pacing in the region of Bachmann’s bundle: Results of a multicenter randomized trial. J Cardiovasc Electrophysiol 2001;12:912-917.

46. Israel CW, Barold SS: Pacing algorithms for prevention of atrial tachyarrhythmias. In Israel CW, Barold SS, eds: Advances in the Treatment of Atrial Tachyarrhythmias: Pacing, Cardioversion and Defibrillation. Armonk, NY: Futura Publishing Co., 2002, pp. 139-171.

47. Carlson M, Ip J, Messenger J, Beau S, Kalbfleisch S, Gervais P, Cameron DA, Duran A, Val-Mejias J, Mackall J, Gold M. A New Pacemaker Algorithm for the Treatment of Atrial Fibrillation. Results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J Am Coll Cardiol 2003;42:627–33.

48. Camm AJ: Preliminary results of the AF Therapy study. Presented at the Hotline Session of the XXIIII. Congress of the European Society of Cardiology, Stockholm, September 3, 2001.

49. Camm AJ: AF therapy study: Preventive pacing for paroxysmal atrial fibrillation. (Abstract) Pacing Clin Electrophysiol 2002;25:125.

50. Padeletti L, Purerfellner H, Adler S, Waller T, Harvey MN, Horvitz L, , Holbrook R, Kempen K ,Mugglin A, Hettrick D: Combined Efficacy of Atrial Septal Lead Placement and Atrial Pacing Algorithms for Prevention of Paroxysmal Atrial Tachyarrhythmia. J Cardiovasc Electrophysiol, Vol. 14; 1189-1195.

51. Lozano IF, Vincent A, Roda J, Méndez M, Ferrer JM, Andrade F, Manzano JJ, Ceres R, Errejon J and Toquero J. Paroxysmal atrial fibrillation prevention by pacing in patients with pacemaker indication. Europace, 5; 267–273

52. Gregoratos G, Cheitlin M.D, Conill A, Epstein A, Fellows C, Ferguson T, et al. ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices. Circulation. 1998;97:1325-1335.

53. Adler S, Wolpert C, Warman EN, Musley SK, Koehler JL, Euler DE. Efficacy of Pacing Therapies for Treating Atrial Tachyarrhythmias in Patients With Ventricular Arrhythmias Receiving a Dual-Chamber Implantable Cardioverter Defibrillator. Circulation;104:887-892.

54. Lee MA, Weachter R, Pollak S, Kremers MS, Naik AM, Silverman R, Tuzi J, Wang W, Johnson LJ, Euler DE. The Effect of Atrial Pacing Therapies on Atrial Tachyarrhythmia Burden and Frequency. J Am Coll Cardiol 2003;41:1926 –32.

55. Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual-Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002; 288:3115-23.

Metadata

Repository Staff Only: item control page

Cogprints is powered by EPrints 3 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.